Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · Real-Time Price · USD

35.01

-0.26 (-0.74%)

At close: Dec 5, 2025, 4:00 PM EST

35.03

+0.02 (0.06%)

After-hours: Dec 5, 2025, 5:55 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2019
Innovative Therapeutics Targeting Serious Viral Diseases	28.52M	Log In	Log In	Log In	Log In	Upgrade
Innovative Therapeutics Targeting Serious Viral Diseases Growth	298.16%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2019
United States	28.52M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	298.16%	Log In	Log In	Log In	Log In	Upgrade